Therapeutic Drug Monitoring Market | Monitoring of Biosimilars in Autoimmune Diseases | Growing at a CAGR of 5.9%

PUNE, India, 2020-May-07 — /EPR Network/ —

[141 Pages Report]The Therapeutic Drug Monitoring Market is projected to reach to reach USD 1.63 billion by 2023 from USD 1.16 billion in 2017 at a CAGR of 5.9% during the forecast period.

The growth of this market is majorly driven by the rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies. However, the lack of financial provisions for the clinical interpretation of TDM results is expected to restrain the growth of this market during the forecast period.

Market Dynamics:

Driver:Use of TDM in traditional anticancer therapies;

TDM provides valuable guidance for the dose adjustment of antibiotics, immunosuppressants, antiepileptics, and other drugs. However, its use in traditional anticancer therapies has been limited. The requirement of multiple blood samples to adequately define the systemic exposure of anticancer drugs is the major issue encountered while testing for anticancer therapies.

Drugs in blood samples have a short elimination half-life and are given by intermittent intravenous injections; this makes the entire monitoring process difficult to analyze. However, newer targeted anticancer therapies have different pharmacokinetic (PK) and dosing characteristics as compared with traditional cytotoxic drugs.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443

By Product, consumables segment was expected to account for a larger share in 2018.

The therapeutic drug monitoring products market is segmented into equipment and consumables. In 2018, the consumables segment was expected to account for a larger share of this market owing to the requirement of repeat purchase of kits and reagents, coupled with the increasing number of immunoassay tests being performed across the globe as a result of the rising incidence of chronic and infectious diseases. Thermo Fisher Scientific (US), F. Hoffmann-La Roche (Switzerland), and Siemens Healthineers (Germany) are some of the key players operating in this market

By Class of Drug, antiepileptic drugs segment is expected to account for the largest share of the therapeutic drug monitoring market in 2018

Based on the class of drugs, the therapeutic drug monitoring market is segmented into antiepileptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive drugs, and other drugs. The antiepileptic drugs segment is expected to account for the largest share of the therapeutic drug monitoring market in 2018. Antiepileptics are the most frequently monitored class of drugs due to their narrow therapeutic range and challenging pharmacokinetics. Antiepileptics, also known as anticonvulsants, are often prescribed for the treatment and management of seizures caused in conditions such as epilepsy and bipolar disorder.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=155350443

Critical questions the report answers:

• Who are the major market players in the therapeutic drug monitoring market?
• What are the growth trends and the largest revenue-generating region for therapeutic drug monitoring?
• How are therapeutic drug monitoring sold to customers?
• What are the major drug classes where therapeutic drug monitoring is used?

In 2018, North America is expected to account for the largest market share, followed by Europe

In this report, the therapeutic drug monitoring market, by region, has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America is expected to account for the largest share of this market, followed by Europe. Growth in the North American market is mainly driven by the increasing per capita healthcare expenditure and the presence of technologically advanced healthcare infrastructure in the region. Initiatives taken by different government associations are also anticipated to boost market growth in the coming years.

Key Market Players;

Abbott Laboratories, Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, Danaher Corporation, Bio-Rad Laboratories, Biomérieux, Bühlmann Laboratories, Sekisui Medical, Randox Laboratories.